Today’s notable healthcare news in Ireland includes a government announcement finalising new framework agreements with Medicines for Ireland and the Irish Pharmaceutical Healthcare Association[3].
Additionally, there is coverage of patient safety concerns, including ISMP errors involving GLP-1 therapies for diabetes and obesity treatment, as reported in a June 25 news release[8].
No comments:
Post a Comment